|
|
Analysis of influencing factors of hospitalization expenses for patients with chronic obstructive pulmonary disease based on diagnosis related groups |
Li Yongfeng1,Yu Chuhong2 |
1 Department of Medical Records, Jiangmen Central Hospital, Jiangmen 529030, China;
2 Medical Insurance Department, Jiangmen Central Hospital, Jiangmen 529030, China |
|
|
Abstract Objective To explore the factors influencing the hospitalization expenses of patients with chronic obstructive pulmonary disease (COPD) in groups related to disease diagnosis. Methods The DRG evaluation of 989 COPD inpatients in a tertiary public hospital in Jiangmen City in 2019 was analyzed. The coefficient of variation CV was used for intra-group comparison, the rank sum test was used for inter-group comparison, and multiple linear regression was used for multivariate analysis of factors influencing hospital expenses. Results COPD patients were mainly distributed in three DRGs, including chronic airway obstructive disease with important comorbidities and concomitant diseases (ET11), chronic airway obstructive disease with comorbidities and concomitant diseases (ET13), and chronic airway obstructive disease without comorbidities and concomitants Disease (ET15). The grouping of ET11 was poor, and the grouping of ET13 and ET15 was better. The time index of the ET11 group was higher than 1, the time consumption index of the ET13 and ET15 groups was lower than 1, and the expense index of the 3 groups were all higher than 1. The difference in hospitalization expenses among the 3 groups was statistically significant. The influencing factors were the length of stay in hospital, rescue, age, and full self-finance for the group ET11; the influencing factors of hospitalization expenses in the ET13 group were the length of hospitalization and the new rural cooperative medical insurance; the influencing factors of hospitalization expenses in the ET15 group were the length of hospitalization. Conclusion DRGs can be used as a management tool to control the hospitalization expenses of COPD patients, and to reduce the hospitalization expenses of COPD patients, thereby to reduce patients′ disease burden.
|
Received: 08 February 2021
|
|
|
|
[1]陶凤然,樊娜,蒋云雯,等.1997—2017年中国人群慢性阻塞性肺病疾病负担趋势分析[J].中国慢性病预防与控制,2020,28(1):3-9.
[2]范晶晶,赵立.慢性阻塞性肺疾病急性加重与呼吸道病毒感染的研究进展[J].国际呼吸杂志,2020,40(2):132-136.
[3]王艳军,孟广平,曲丹华,等.慢性阻塞性肺疾病患者肺康复诊治进展[J].中国老年学杂志,2021,41(2):415-420.
[4]杨业春.疾病诊断相关分组和加权TOPSIS法在中医医院专科住院医疗绩效评价中的应用[J].中国医院统计,2018,25(6):426-429.
[5]万钢,桑雁,郝一炜,等.基于疾病诊断相关组的秩和比法对医院绩效评价[J].中国医院统计,2016,23(1):19-21.
[6]舒琴,李迪,孙扬,等.基于变异系数计算的DRG本土化应用分析及建议[J].中国医院管理,2019,39(8):43-45.
[7]郑敏娜,唐星月,张清.生活方式对慢性阻塞性肺疾病患者认知功能的影响[J].重庆医学,2020,49(23):3946-3950.
[8]秦国双,温昊于,宇传华.中国COPD的患病发病及YLD现状及趋势[J].公共卫生与预防医学,2019,30(2):4-8.
[9]周林,刘月玲,张军,等.2011—2014年济南市慢性阻塞性肺疾病死亡特征和疾病负担分析[J].中国卫生统计,2016,33(2):280-281.
[10]付睿,蔡乐.基于DRGs的云南某医院COPD患者重复入院影响因素分析[J].昆明医科大学学报,2021,42(1):59-63.
[11]李伟文.某院近5年住院老年慢性阻塞性肺疾病急性加重期患者死亡状况及影响因素分析[J].中国医院统计,2017,24(4):280-282.
[12]杨帆.3 849例慢性阻塞性肺病伴有急性加重住院患者费用分析[J].中国病案,2020,21(7):53-56.
[13]王琨,蒋雷,张灿宏,等.基于DRGs的临床路径住院费用分析[J].中国卫生质量管理,2019,26(4):28-30.
|
[1] |
Yun Xiaoyan, Chen Zhonghu, Yang Yan.. Structural variation analysis and influencing factors of hospitalization expenses of patients with malignant tumor[J]. journal1, 2021, 28(4): 334-338. |
[2] |
Xu Mengqiu, Ding Liping. . Analysis of delivery situation and hospitalization expenses related to birth policy of two-child puerpera.[J]. journal1, 2021, 28(2): 157-161. |
[3] |
He Liping, Zheng Lijiao, Liu Yuanting.. Evaluation of the effect of bed allocation by using indicators of diagnosis related groups .[J]. journal1, 2021, 28(2): 175-180. |
[4] |
Wu Linghong, Ding Li, Ding Rensheng.. Analysis of factors influencing hospitalization cost of stroke patients based on structural equation model.[J]. journal1, 2021, 28(2): 143-148. |
[5] |
Liu Wenhao, Wang Jiu. Analysis of the initial hospitalization expenses and its influencing factors for children with acute leukemia[J]. journal1, 2020, 27(6): 518-521. |
[6] |
Xu Mengqiu, Ding Liping.. Discussion on diagnosis related groups of prostatic cancer based on hospitalization expenses[J]. journal1, 2020, 27(5): 416-419. |
|
|
|
|